Agilent Technologies ( (A) ) has released its Q3 earnings. Here is a breakdown of the information Agilent Technologies presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Agilent Technologies Inc. is a global leader in analytical and clinical laboratory technologies, providing instruments, software, services, and expertise to deliver trusted answers to complex scientific questions.
In its third-quarter fiscal year 2025 earnings report, Agilent Technologies announced a strong revenue growth of $1.74 billion, surpassing its revenue guidance and marking a 10.1% increase compared to the same period last year. The company also reported a significant rise in both GAAP and non-GAAP net income.
Key financial highlights include a GAAP net income of $336 million with earnings per share (EPS) of $1.18, marking a 22% increase from the previous year. The non-GAAP net income was reported at $390 million, with an EPS of $1.37, reflecting a 4% increase. All three business segments, including Life Sciences and Diagnostics, Agilent CrossLab, and Applied Markets, showed notable revenue growth.
Looking ahead, Agilent has revised its full-year revenue outlook to a range of $6.91 billion to $6.93 billion, with an expected non-GAAP EPS between $5.56 and $5.59. The company remains optimistic about its growth prospects, driven by its strategic initiatives and strong execution capabilities.